El género Profundulus Hubbs, 1924 (Actinopterygii: Profundulidae): sistemática, filogenia y biogeografía

Tesis Doctoral inédita leída en la Universidad Autónoma de Madrid, Facultad de Ciencias, Departamento de Ecología. Fecha de lectura: 31-05-200

Estudio de comunidades de matorral mediterráneo II

Conjunto de guiones de prácticas de Ecología, correspondientes al bloque temático sobre el estudio de comunidades, centrado en el análisis de la diversidad de las comunidades presentes en el territorio objeto de estudio, y su respuesta a la perturbación. Acompañan dos archivos Excel de ejemplo, y el simulador de distribuciones de datos de vegetación

Fish morphology and passage through velocity barriers. Experience with northern straight-mouth nase (Pseudochondrostoma duriense Coelho, 1985) in an open channel flume

Knowing the relationship between size, morphological traits and swimming performance of fish is essential to understand the swimming capacity to successfully surpass these obstacles and the selective pressure that barriers in rivers and streams could exert on fish. Northern straight-mouth nase, an endemic potamodromous cyprinid fish species from the Northwest of the Iberian Peninsula, was selected to carry out volitionally swimming performance experiments in an open channel against three different flow velocities, using telemetry and video cameras. The use of thin-plate spline, on 10 landmarks, evidenced unknown patterns linked to velocity barriers. At lower flow velocity, size is the main factor explaining the swimming performance; thus, large individuals swim up more efficiently. In contrast, at high flow velocities, shape becomes the essential explanatory variable; thereby, streamlined body shapes with a higher relative position of the tail and a narrower caudal peduncle are more efficient. The obtained results show the existence of a relationship between fish morphology and swimming performance, with potential consequences due to selection pressures associated with velocity barriers and their implications on behavioural and dispersal processes. To sum up, velocity barriers could exert a selection pressure on nase populations, so the fishway design and removal should be (re)considered

Enseñar Ecología hoy: abandonando la tarima para jugar con el mundo real

Depto. de Biodiversidad, Ecología y EvoluciónFac. de Ciencias BiológicasFALSEsubmitte

Practice-oriented solutions integrating intraoperative electron irradiation and personalized proton therapy for recurrent or unresectable cancers: Proof of concept and potential for dual FLASH effect

BackgroundOligo-recurrent disease has a consolidated evidence of long-term surviving patients due to the use of intense local cancer therapy. The latter combines real-time surgical exploration/resection with high-energy electron beam single dose of irradiation. This results in a very precise radiation dose deposit, which is an essential element of contemporary multidisciplinary individualized oncology.MethodsPatient candidates to proton therapy were evaluated in Multidisciplinary Tumor Board to consider improved treatment options based on the institutional resources and expertise. Proton therapy was delivered by a synchrotron-based pencil beam scanning technology with energy levels from 70.2 to 228.7 MeV, whereas intraoperative electrons were generated in a miniaturized linear accelerator with dose rates ranging from 22 to 36 Gy/min (at Dmax) and energies from 6 to 12 MeV.ResultsIn a period of 24 months, 327 patients were treated with proton therapy: 218 were adults, 97 had recurrent cancer, and 54 required re-irradiation. The specific radiation modalities selected in five cases included an integral strategy to optimize the local disease management by the combination of surgery, intraoperative electron boost, and external pencil beam proton therapy as components of the radiotherapy management. Recurrent cancer was present in four cases (cervix, sarcoma, melanoma, and rectum), and one patient had a primary unresectable locally advanced pancreatic adenocarcinoma. In re-irradiated patients (cervix and rectum), a tentative radical total dose was achieved by integrating beams of electrons (ranging from 10- to 20-Gy single dose) and protons (30 to 54-Gy Relative Biological Effectiveness (RBE), in 10–25 fractions).ConclusionsIndividual case solution strategies combining intraoperative electron radiation therapy and proton therapy for patients with oligo-recurrent or unresectable localized cancer are feasible. The potential of this combination can be clinically explored with electron and proton FLASH beams

Estudio de comunidades de matorral mediterráneo I

Conjunto de guiones de prácticas de Ecología, correspondientes al bloque temático sobre el estudio de comunidades, y material complementario (estadillo y plantilla para la matriz de datos)

Guía Rápida de SPSS v.25 (Prácticas de Ecología)

Guía rápida de SPSS v.25 para usar en las Prácticas de Ecología (Grado en Biología, 3er curso

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio